Constantin d’Ydewalle

HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease

Constantin d’Ydewalle, Jyothsna Krishnan, Driss M Chiheb et al. · Nature Medicine · 2011 · 458 citations · Full text

Signal Transduction, Hdac6 Inhibitors, Signaling Pathway +11

Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment

Daniel M. Ramos, Constantin d’Ydewalle, Vijayalakshmi Gabbeta et al. · Journal of Clinical Investigation · 2019 · 183 citations · Full text

Backgroundspinal Muscular Atrophy, Disease Progression, Pathology +23

The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy

Constantin d’Ydewalle, Daniel M. Ramos, Noah J. Pyles et al. · Neuron · 2016 · 133 citations · Full text

Musculoskeletal Research, Degenerative Disease, Novel Therapeutic Target +5

HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease

Veronick Benoy, Lawrence Van Helleputte, Robert Prior et al. · Brain · 2017 · 119 citations · Full text

Hdac6 Inhibition, Molecular Biology, Pathology +19

Small Heat-Shock Protein HSPB1 Mutants Stabilize Microtubules in Charcot-Marie-Tooth Neuropathy

Leonardo Almeida‐Souza, Bob Asselbergh, Constantin d’Ydewalle et al. · Journal of Neuroscience · 2011 · 103 citations · Full text

Mutant Hspb1, Signal Transduction, Molecular Neuroscience +13